Renal Cancers Terminated Phase 2 Trials for Imatinib (DB00619)

Also known as: Renal Cancer / Kidney Cancer / Renal malignant neoplasm / Renal neoplasms malignant / Cancer of Kidney

IndicationStatusPhase
DBCOND0044624 (Renal Cancers)Terminated2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00323791Gemcitabine With or Without Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Kidney CancerTreatment